Barclays analyst Michael Leithead maintained a Hold rating on Chemours Company (CC – Research Report) today and set a price target of $16.00.

and The Chemours Company (NYSE: CC) today announced they are forming a strategic alliance to expand the companies' existing relationship to enhance U.S. domestic rare earth and critical mineral ...